Table 4

Episodes of antibiotic-induced neutropenia

Patient no.Indication for antibioticsDrugsDays after gene therapy at start of antibiotic treatmentBaseline neutrophil count, cells/μL*Neutrophil nadir, cells/μLTime to neutrophil nadir, daysTime to recovery of ANC to > 500 cells/μL without G-CSF, d
ADA10 Catheter exit site infection Oxacillin, vancomycin 84 1290 270 20 74 
ADA14 Surgical prophylaxis Cefazolin 361 3677 764 NA 
ADA16 S epidermidis bacteremia Vancomycin; TMP/SFX, fluconazole acyclovir, rifampin, ethambutol, isoniazid, clarithromycin Treatment started prior to gene therapy 3023 449 31 37 
 Pneumonia Ceftriaxone, amoxicillin/clavulanic acid, azithromycin 63 2858 373 14 15 
 Pneumonia/E coli bacteremia Meropenem, amoxicillin/clavulanic acid azithromycin 546 4620 387 11 37 
 Otitis media Levofloxacin, Linezolid 1463 1110 680 15 NA 
 Fever Azithromycin 1487 3490 490 
Patient no.Indication for antibioticsDrugsDays after gene therapy at start of antibiotic treatmentBaseline neutrophil count, cells/μL*Neutrophil nadir, cells/μLTime to neutrophil nadir, daysTime to recovery of ANC to > 500 cells/μL without G-CSF, d
ADA10 Catheter exit site infection Oxacillin, vancomycin 84 1290 270 20 74 
ADA14 Surgical prophylaxis Cefazolin 361 3677 764 NA 
ADA16 S epidermidis bacteremia Vancomycin; TMP/SFX, fluconazole acyclovir, rifampin, ethambutol, isoniazid, clarithromycin Treatment started prior to gene therapy 3023 449 31 37 
 Pneumonia Ceftriaxone, amoxicillin/clavulanic acid, azithromycin 63 2858 373 14 15 
 Pneumonia/E coli bacteremia Meropenem, amoxicillin/clavulanic acid azithromycin 546 4620 387 11 37 
 Otitis media Levofloxacin, Linezolid 1463 1110 680 15 NA 
 Fever Azithromycin 1487 3490 490 

TMP/SFX indicates trimethoprim/sulfamethoxazole; and NA, not applicable.

*

Neutrophil count immediately before antibiotic treatment.

or Create an Account

Close Modal
Close Modal